Chondrodysplasia punctata and neonatal lupus in an infant with positive anti-RNP and negative anti-Ro/SSA and -La/SSB antibodies, a case report

Pediatr Dermatol. 2020 Sep;37(5):925-928. doi: 10.1111/pde.14312. Epub 2020 Aug 4.

Abstract

Rhizomelic chondrodysplasia punctata is a rare, often fatal disease that shares many clinical dysmorphologic features with the rare often non-lethal chondrodysplasia punctata due to maternal autoimmune disease. Characteristic findings of both conditions include mid-face hypoplasia, stippled epiphyses of the vertebrae and long bones, and growth failure. A growing association with anti-ribonucleoprotein antibodies is emerging amongst patients with chondrodysplasia punctata due to maternal autoimmune disease and also neonatal lupus that have potential important screening implications. We present a unique case of chondrodysplasia punctata with neonatal lupus in the setting of positive anti-RNP antibodies and negative anti-Ro/SSA and -La/SSB antibodies born to a mother with mixed connective tissue disease and Raynaud's syndrome.

Keywords: Neonatal lupus; chondrodysplasia punctata; maternal autoantibodies; maternal autoimmune disease.

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Antinuclear
  • Chondrodysplasia Punctata* / diagnosis
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Lupus Erythematosus, Systemic / congenital*
  • Mothers

Substances

  • Antibodies, Antinuclear

Supplementary concepts

  • Neonatal Systemic lupus erythematosus